Volume | 3,370 |
|
|||||
News | - | ||||||
Day High | 17.55 | Low High |
|||||
Day Low | 17.30 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
SWK Holdings Corporation | SWKH | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
17.32 | 17.30 | 17.55 | 17.58 | 17.48 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
172 | 3,370 | $ 17.42 | $ 58,696 | - | 15.26 - 18.75 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:06 | 1 | $ 17.58 | USD |
SWK Holdings Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
313.2M | 12.50M | - | 44.06M | 15.89M | 1.27 | 19.72 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
SWK News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SWKH Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 17.69 | 17.73 | 17.05 | 17.45 | 4,866 | -0.11 | -0.62% |
1 Month | 17.10 | 17.75 | 16.78 | 17.36 | 5,651 | 0.48 | 2.81% |
3 Months | 16.98 | 18.488 | 15.92 | 17.25 | 10,790 | 0.60 | 3.53% |
6 Months | 15.89 | 18.75 | 15.65 | 17.19 | 9,108 | 1.69 | 10.64% |
1 Year | 17.28 | 18.75 | 15.26 | 16.80 | 9,296 | 0.30 | 1.74% |
3 Years | 15.91 | 20.4945 | 15.26 | 18.00 | 14,956 | 1.67 | 10.50% |
5 Years | 14.00 | 20.4945 | 6.12 | 16.89 | 14,298 | 3.58 | 25.57% |
SWK Description
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment. |